“PEGASEMP™ allows inhibition of tumor growth and prevents metastization of mesothelioma, with low incidence of side effects. PEGASEMP™ is the lead product of TREAT U that has just received the Orphan Drug designation (ODD) in the treatment of malignant mesothelioma … Continue reading →

Portugal Ventures challenged Vera Moura, our CEO, to describe the journey of a startup in Life Sciences sector. From “the commitment of a team”, “the growing pains” up to “finding a lead investor”, she is an example for others to … Continue reading →

TREAT U was present in the BIO International Convention 2017, held in the San Diego Convention Center in June. Associated with Biocant Park, a technological center of reference in Portugal, and P-BIO, Portugal’s Biotechnology Industry Organization, seven biotech Portuguese companies … Continue reading →

TREAT U was one of six finalists for the Everis Awards, the awards for entrepreneurship, innovation and talent, with the PEGASEMP project. This award, promoted by the Everis Foundation (Spain) was created to encourage entrepreneurship in society and promote innovation … Continue reading →